SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
97 hedge funds and large institutions have $147M invested in Sorrento Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+3
Holders Change %
+3.19%
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
29
Reduced
22
Closed
15
Calls
$249K
Puts
$2M
Net Calls
-$1.75M
Net Calls Change
+$1.54M
Top Buyers
| 1 |
BlackRock
New York
|
+$6.29M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$6.02M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.07M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.6M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.26M |
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$2.01M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.23M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.21M |
| 4 |
Renaissance Technologies
New York
|
-$1.12M |
| 5 |
Millennium Management
New York
|
-$1.08M |
